Stereotaxis Ord Financials
This page shows Stereotaxis Ord (STXS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Stereotaxis Ord has an operating margin of -91.9%, meaning the company retains $-92 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -81.6% the prior year.
Stereotaxis Ord's revenue grew a modest 0.5% year-over-year to $26.9M. This slow but positive growth earns a score of 30/100.
Stereotaxis Ord has elevated debt relative to equity (D/E of 5.80), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Stereotaxis Ord's current ratio of 1.22 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 29/100, which could limit financial flexibility.
While Stereotaxis Ord generated -$8.5M in operating cash flow, capex of $34K consumed most of it, leaving -$8.5M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Stereotaxis Ord passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Stereotaxis Ord generates $0.35 in operating cash flow (-$8.5M OCF vs -$24.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Stereotaxis Ord earns $-35.3 in operating income for every $1 of interest expense (-$24.7M vs $700K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Stereotaxis Ord generated $26.9M in revenue in fiscal year 2024. This represents an increase of 0.5% from the prior year.
Stereotaxis Ord's EBITDA was -$23.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 11.8% from the prior year.
Stereotaxis Ord generated -$8.5M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 10.2% from the prior year.
Stereotaxis Ord reported -$24.0M in net income in fiscal year 2024. This represents a decrease of 16.1% from the prior year.
Stereotaxis Ord earned $-0.30 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 11.1% from the prior year.
Stereotaxis Ord held $12.2M in cash against $0 in long-term debt as of fiscal year 2024.
Stereotaxis Ord's gross margin was 54.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 1.3 percentage points from the prior year.
Stereotaxis Ord's operating margin was -91.9% in fiscal year 2024, reflecting core business profitability. This is down 10.3 percentage points from the prior year.
Stereotaxis Ord's net profit margin was -89.3% in fiscal year 2024, showing the share of revenue converted to profit. This is down 12.0 percentage points from the prior year.
Stereotaxis Ord invested $9.8M in research and development in fiscal year 2024. This represents a decrease of 5.0% from the prior year.
Stereotaxis Ord invested $34K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 90.7% from the prior year.
STXS Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5M-15.2% | $8.8M+17.7% | $7.5M+17.9% | $6.3M+40.8% | $4.5M-34.6% | $6.9M+50.7% | $4.6M-41.5% | $7.8M |
| Cost of Revenue | $3.4M-20.3% | $4.2M+23.8% | $3.4M+9.1% | $3.1M+162.7% | $1.2M-59.2% | $2.9M+59.5% | $1.8M-51.1% | $3.7M |
| Gross Profit | $4.1M-10.4% | $4.6M+12.7% | $4.1M+26.4% | $3.2M-2.9% | $3.3M-16.5% | $4.0M+44.9% | $2.7M-32.5% | $4.1M |
| R&D Expenses | $2.5M+43.3% | $1.8M-24.4% | $2.4M-15.8% | $2.8M+22.7% | $2.3M+1.3% | $2.2M+1.4% | $2.2M-17.1% | $2.7M |
| SG&A Expenses | $5.2M+29.4% | $4.0M-11.0% | $4.5M-12.5% | $5.1M+36.6% | $3.8M+8.5% | $3.5M+14.1% | $3.0M-22.7% | $3.9M |
| Operating Income | -$6.6M-64.9% | -$4.0M+32.9% | -$5.9M+22.3% | -$7.6M-26.7% | -$6.0M-26.9% | -$4.7M+10.5% | -$5.3M+5.9% | -$5.6M |
| Interest Expense | $91K-40.1% | $152K+43.4% | $106K-11.7% | $120K-37.2% | $191K-20.1% | $239K-8.4% | $261K-3.3% | $270K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$6.5M-68.9% | -$3.8M+34.3% | -$5.8M+22.5% | -$7.5M-28.8% | -$5.8M-29.4% | -$4.5M+10.6% | -$5.0M+6.1% | -$5.4M |
| EPS (Diluted) | $-0.07-40.0% | $-0.05+28.6% | $-0.07+22.2% | $-0.09-28.6% | $-0.07-16.7% | $-0.060.0% | $-0.06+14.3% | $-0.07 |
STXS Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.6M+10.7% | $41.2M-9.9% | $45.7M-2.2% | $46.7M+29.7% | $36.0M-8.7% | $39.5M-5.9% | $41.9M-5.9% | $44.5M |
| Current Assets | $26.7M+21.7% | $21.9M-15.5% | $25.9M-2.0% | $26.4M-5.8% | $28.1M-10.0% | $31.2M-6.2% | $33.3M-6.3% | $35.5M |
| Cash & Equivalents | $10.5M+50.8% | $7.0M-34.3% | $10.6M-13.2% | $12.2M-16.8% | $14.7M-16.7% | $17.6M-11.0% | $19.8M-10.3% | $22.1M |
| Inventory | $10.1M+5.6% | $9.6M-2.1% | $9.8M+17.8% | $8.3M-10.3% | $9.3M+12.5% | $8.3M-2.1% | $8.4M+24.1% | $6.8M |
| Accounts Receivable | $5.3M+21.4% | $4.4M+1.6% | $4.3M+13.1% | $3.8M+37.5% | $2.8M-29.6% | $4.0M+3.4% | $3.8M-27.1% | $5.2M |
| Goodwill | $3.8M0.0% | $3.8M0.0% | $3.8M0.0% | $3.8M | N/A | N/A | N/A | N/A |
| Total Liabilities | $34.1M-1.1% | $34.4M-8.3% | $37.5M+6.3% | $35.3M+83.3% | $19.3M-0.9% | $19.4M-2.8% | $20.0M-1.2% | $20.2M |
| Current Liabilities | $20.4M-1.8% | $20.7M-14.4% | $24.2M+12.2% | $21.6M+76.3% | $12.3M-4.7% | $12.9M-3.0% | $13.2M+1.6% | $13.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $6.3M+330.4% | $1.5M-49.4% | $2.9M-52.6% | $6.1M-46.5% | $11.4M-22.0% | $14.6M-10.9% | $16.3M-12.7% | $18.7M |
| Retained Earnings | -$577.8M-1.1% | -$571.4M-0.7% | -$567.5M-1.0% | -$561.7M-2.5% | -$548.0M-1.1% | -$542.2M-0.8% | -$537.7M-0.9% | -$532.6M |
STXS Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.2M-12.6% | -$3.7M-109.8% | -$1.8M-240.5% | $1.3M+141.0% | -$3.1M-31.6% | -$2.3M+3.8% | -$2.4M-152.2% | -$967K |
| Capital Expenditures | $0 | N/A | N/A | $2K | N/A | N/A | $0-100.0% | $10K |
| Free Cash Flow | -$4.2M | N/A | N/A | $1.3M | N/A | N/A | -$2.4M-149.6% | -$977K |
| Investing Cash Flow | $0 | N/A | N/A | -$2K | N/A | N/A | $0+100.0% | -$10K |
| Financing Cash Flow | $7.7M+22673.5% | $34K+6.3% | $32K-79.9% | $159K+467.9% | $28K-6.7% | $30K+15.4% | $26K+4.0% | $25K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
STXS Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.9%+2.9pp | 52.0%-2.3pp | 54.4%+3.7pp | 50.7%-22.9pp | 73.6%+15.9pp | 57.6%-2.3pp | 60.0%+7.9pp | 52.0% |
| Operating Margin | -87.8%-42.6pp | -45.2%+34.1pp | -79.3%+41.0pp | -120.3%+13.4pp | -133.7%-64.8pp | -69.0%+47.2pp | -116.2%-43.9pp | -72.3% |
| Net Margin | -86.6%-43.1pp | -43.5%+34.4pp | -77.9%+40.6pp | -118.5%+11.0pp | -129.6%-64.1pp | -65.5%+44.9pp | -110.4%-41.6pp | -68.8% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -14.2%-4.9pp | -9.3%+3.5pp | -12.7%+3.3pp | -16.1%+0.1pp | -16.2%-4.8pp | -11.4%+0.6pp | -12.0%+0.0pp | -12.1% |
| Current Ratio | 1.31+0.3 | 1.06-0.0 | 1.07-0.2 | 1.22-1.1 | 2.29-0.1 | 2.43-0.1 | 2.51-0.2 | 2.73 |
| Debt-to-Equity | 5.43-18.2 | 23.64+10.6 | 13.03+7.2 | 5.80+4.1 | 1.70+0.4 | 1.33+0.1 | 1.22+0.1 | 1.08 |
| FCF Margin | -56.3% | N/A | N/A | 19.9% | N/A | N/A | -53.4%-40.9pp | -12.5% |
Similar Companies
Frequently Asked Questions
What is Stereotaxis Ord's annual revenue?
Stereotaxis Ord (STXS) reported $26.9M in total revenue for fiscal year 2024. This represents a 0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Stereotaxis Ord's revenue growing?
Stereotaxis Ord (STXS) revenue grew by 0.5% year-over-year, from $26.8M to $26.9M in fiscal year 2024.
Is Stereotaxis Ord profitable?
No, Stereotaxis Ord (STXS) reported a net income of -$24.0M in fiscal year 2024, with a net profit margin of -89.3%.
What is Stereotaxis Ord's earnings per share (EPS)?
Stereotaxis Ord (STXS) reported diluted earnings per share of $-0.30 for fiscal year 2024. This represents a -11.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Stereotaxis Ord's EBITDA?
Stereotaxis Ord (STXS) had EBITDA of -$23.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Stereotaxis Ord's gross margin?
Stereotaxis Ord (STXS) had a gross margin of 54.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Stereotaxis Ord's operating margin?
Stereotaxis Ord (STXS) had an operating margin of -91.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Stereotaxis Ord's net profit margin?
Stereotaxis Ord (STXS) had a net profit margin of -89.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Stereotaxis Ord's free cash flow?
Stereotaxis Ord (STXS) generated -$8.5M in free cash flow during fiscal year 2024. This represents a 10.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Stereotaxis Ord's operating cash flow?
Stereotaxis Ord (STXS) generated -$8.5M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Stereotaxis Ord's total assets?
Stereotaxis Ord (STXS) had $46.7M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Stereotaxis Ord's capital expenditures?
Stereotaxis Ord (STXS) invested $34K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Stereotaxis Ord spend on research and development?
Stereotaxis Ord (STXS) invested $9.8M in research and development during fiscal year 2024.
What is Stereotaxis Ord's current ratio?
Stereotaxis Ord (STXS) had a current ratio of 1.22 as of fiscal year 2024, which is considered adequate.
What is Stereotaxis Ord's debt-to-equity ratio?
Stereotaxis Ord (STXS) had a debt-to-equity ratio of 5.80 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stereotaxis Ord's return on assets (ROA)?
Stereotaxis Ord (STXS) had a return on assets of -51.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Stereotaxis Ord's cash runway?
Based on fiscal year 2024 data, Stereotaxis Ord (STXS) had $12.2M in cash against an annual operating cash burn of $8.5M. This gives an estimated cash runway of approximately 17 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Stereotaxis Ord's Piotroski F-Score?
Stereotaxis Ord (STXS) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stereotaxis Ord's earnings high quality?
Stereotaxis Ord (STXS) has an earnings quality ratio of 0.35x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Stereotaxis Ord cover its interest payments?
Stereotaxis Ord (STXS) has an interest coverage ratio of -35.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Stereotaxis Ord?
Stereotaxis Ord (STXS) scores 12 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.